SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Teslas scheduled Cybercab/robotaxi launch, alongside reported expansion of unsupervised Austin testing and fleet additions, is driving attention. Traders are divided between bullish expectations that autonomy will accelerate Teslas AI and mobility opportunity and concerns that the event may trigger a buy the rumor, sell the news reversal amid valuation and execution risks.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Recent strong earnings and BioCrysts profitable Orladeyo franchise are being weighed against unconfirmed buyout speculation and the companys shift toward acquiring external rare-disease assets. Traders remain divided, with bullish investors focused on pediatric Orladeyo growth and future navenibart data, while others cite competition, pipeline uncertainty, low volume, and stagnant price action.

Zoracles

A sharp price and volume surge has pushed ZORA into focus, with traders citing its small market cap, rising activity and potentially crowded futures shorts as fuel for a short squeeze. Others caution that the move may be a speculative pump-and-dump, leaving the fundamental catalyst unconfirmed.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

U.S.-Iran military escalation, including strikes near the Strait of Hormuz, is the dominant market-related discussion, with traders linking the conflict to higher oil prices, inflation and broader market risk. Supporters argue Trumps Iran and Venezuela energy actions could improve stability and supply, while critics view the war and trade policies as costly, destabilizing and damaging to the economy.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Attention centers on SELLASs event-driven REGAL Phase 3 trial, which remains officially at 78 of 80 events and is nearing the milestone that triggers final efficacy analysis for GPS in AML. Traders are divided between bullish interpretations of the prolonged event accrual and industry comments calling GPS a potential game changer, and bearish concerns about trial design, control-arm survival, and the binary readout risk.

GE Vernova, Inc. engages in the electric power industry. It operates through the following segments: Power, Wind, and Electrification. The Power segment offers design, manufacture, and servicing gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment manages wind generation technologies, including onshore and offshore wind turbines and blades. The Electrification segment refers to the grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The company was founded November 9, 2021 and is headquartered in Cambridge, MA.

GE Vernova Inc.

GE Vernovas quarterly report is driving attention: an earnings miss and ongoing Wind-segment weakness triggered a sharp selloff despite a revenue beat, raised full-year guidance, and record backlog. Traders are split between viewing the reaction as profit-taking or valuation pressure and arguing that sustained AI data-center, electrification, and grid demand supports the long-term power-infrastructure thesis.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Anticipation of Apples September iPhone launchits first major event under incoming CEO John Ternus, with a possible foldable iPhone and Siri AI upgradesis driving attention and bullish options positioning. Traders debate whether the event can justify the companys valuation, with skeptics citing slowing demand, memory costs, and the risk of a pre-event run-up followed by a sell-the-news reaction.

Airbnb, Inc. engages in the management and operation of an online marketplace. Its marketplace model connects hosts and guests online or through mobile devices to book spaces. The company was founded by Brian Chesky, Nathan Blecharczyk and Joseph Gebbia in 2007 and is headquartered in San Francisco, CA.

Airbnb Inc - Ordinary Shares - Class A

Airbnb Inc

A strong Q2 earnings beat, raised full-year outlook, and resilient travel demandhelped by World Cup bookingshave driven Airbnb shares to fresh multi-year highs and fueled bullish momentum. Traders remain divided, with some citing AI-enabled efficiency, cash flow, and platform expansion, while others warn the rally has left the stock overvalued and exposed to regulatory, insider-selling, and post-earnings pullback risks.

Helium is a decentralized machine network powered by a physical blockchain. The network is created by gateways who also double as miners on our network. These gateway operators can earn tokens based on coverage they provide as well as transaction fees gained from machines connecting to their gateway  Helium is a new cryptocurrency. Hotspots earn for providing and validating wireless coverage and when devices on the network connect to the internet through Hospots  Helium is mined and distributed to Hotspot Owners, Helium Inc, and investors. There is no pre-mine of Helium, and every month approximately 5,000,000 new Helium are minted.  At the end of each mining period, roughly every 30 to 60 mins, Helium is distributed according to the allocation shown:

Helium

Heliums rally is being attributed to Celina, Texas converting municipal WiFi into Helium carrier coverage, alongside broader discussion of AT&T integrations, mobile adoption, and DePIN utility. Traders are divided between viewing the developments as evidence of real-world network growth and warning that token dilution, weak hotspot economics, and selling pressure could undermine the move.

Abercrombie & Fitch Co. engages in the retail of apparel, personal care products, and accessories. The firm operates through following geographical segments: Americas, Europe, the Middle East and Africa (EMEA), and Asia-Pacific (APAC). Its brands include Abercrombie and Hollister. The company was founded by David Abercrombie in 1892 and is headquartered in New Albany, OH.

Abercrombie & Fitch Co. - Ordinary Shares - Class A

Abercrombie & Fitch Co.

A strong Q2 earnings beat, raised full-year outlook, and expanded buyback plan have driven ANFs sharp rally, with traders also citing short covering and momentum. Bulls point to resilient brand demand and continued growth, while bears argue the results were boosted by a one-time tariff refund and that the stock is now overextended.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BNTX Stock On Track For Worst Day Since March After Cancer Vaccine Trial Halt — BMO Capital Terms It ‘Clear Setback’

Equity

BioNTech said on Friday that it and its partner, Genentech, a Roche unit, are ending the mid-stage study of autogene cevumeran, used alone after surgery, in certain high-risk stage II or III colorectal cancer patients. 


Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine

Pfizer Inc. (NYSE: PFE, Pfizer) and BioNTech SE (Nasdaq: BNTX, BioNTech) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for the companies 2026-2027 COVID-19 vaccine formula targeting the XFG variant (COMIRNATY XFG...

A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity

A New Generation of Personalized Cancer Treatments Could Open a Multibillion-Dollar Market for Precision Oncology   New York, NY – August 26, 2026 – Market News Updates News Commentary – If watching where cancer treatment is headed, mRNA cancer vaccines are hard to ignore—especially in lung cancer. The basic idea is surprisingly straightforward: instead of […]
The post A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity appeared first on Financial News Media.

Should You Buy Moderna Stock Following Its Cancer Breakthrough?

MRNA's cancer therapy scores a phase III win, strengthening its mRNA platform, while pipeline risks and competition remain key concerns.

ARCT Surges Over 60% Toward Best Week In Year As Moderna Cancer Win Lifts Sector — Retail Says Arcturus Getting ‘Harder To Dismiss’

ARCT stock was most recently buoyed by positive late-stage results from Merck and Moderna on their personalized mRNA cancer vaccine combined with Keytruda in high-risk melanoma patients.


SLS, IBRX Stocks In Focus: Analyst Says Moderna-Merck Cancer Vaccine Success ‘Bodes Well’ For Oncology

Moderna soared 177% Wednesday, while Merck gained 13% and the rally spread to BioNTech, Arcturus, Tempus AI and Novavax.

ARCT Defies mRNA Selloff And Extends Rally As Moderna, BioNTech Shares Pull Back

The rally around MRNA names began on Wednesday after Merck and Moderna reported positive late-stage results for their personalized mRNA cancer vaccine combined with Keytruda in high-risk melanoma patients.


Is Cancer the Next Breakthrough for Moderna After COVID-19?

MRNA's cancer therapy scores a first phase III win, fueling hopes its mRNA platform can drive growth beyond COVID-19 vaccines.

Moderna Is Now S&P 500’s No. 2 Stock This Year — Wall Street, Jim Cramer And Elon Musk Cheer Cancer Vaccine Breakthrough

The breakthrough sparked a broad biotech rally, lifting Merck, BioNTech, Arcturus, cancer-treatment developers, gene-editing stocks and biotech ETFs.

TEM, BNTX, MRVI, RGEN, NVAX Stock Rallies As Moderna-Merck Cancer Vaccine Clears Late-stage Trial 

TEM stock rose as investors connected the upbeat clinical results to Tempus’s planned $1.5 billion acquisition of Personalis, announced last month.


• Reported GAAP EPS of -$3.24 down -102.50% YoY
• Reported revenue of $145.8M down -44.10% YoY
• BioNTech is revising its full-year 2026 revenue guidance to 1.61.9 billion, while maintaining adjusted SG&A expenses at 700800 million and adjusting R&D expense guidance to 2.02.3 billion for BioNTech.

BioNTech faces significant financial pressure, evidenced by a substantial net loss increase and a downward revision to full-year 2026 revenue guidance, primarily driven by declining COVID-19 vaccine demand for BioNTech.

BioNTech continues to aggressively advance its late-stage oncology pipeline with multiple pivotal trials and achieved regulatory approval for its new COVID-19 vaccine, supported by a strong cash position for BioNTech.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

BNTX BioNTech SE - ADR

Fundamentals

Connect Stocktwits to ChatGPT

Latest BNTX News